Prexton Therapeutics
Copenhagen, DK · 3 known investors
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions. The company serves patients and healthcare providers worldwide across the neuroscience field.
BiotechHealthtechMedical Devices
Investors · 3
In the news
- M&A of the Year: Prexton Therapeutics - Global Venturingglobalventuring.com · 2019
- Newcomer Appello raises $10.5M for new Vanderbilt Parkinson’s drug | Fierce Biotechfiercebiotech.com · 2018
- Prexton Acquired by Lundbeck for up to €905m. – Seroba Lifesciencesserobavc.com · 2018
- Serono spinout raises €29M for phase 2 Parkinson’s trials | Fierce Biotechfiercebiotech.com · 2017
- Prexton Therapeutics raises €8.7 million ($10 million) in a Series A round – Ysios Capitalysioscapital.com · 2015
- Prexton Therapeutics Raises €8.7M in Series A Funding - FinSMEsfinsmes.com · 2015